Raydium rallied across cryptocurrency markets following Injective's expansion to Solana, which positioned the platform as a day-one liquidity partner for the new blockchain launch. This integration enabled immediate trading of Injective ecosystem tokens through Raydium's decentralized exchange.
The timing coincided with broader market strength. RAY's price gained 15.19% over 24 hours, while trading volume surged 125.5%. Over the course of the rally, Raydium's daily chart extended gains by approximately 26%, briefly reaching $1.85 before retracing.
Raydium dominates Solana trading activity, accounting for over 90% of memecoin DEX trading volume on the blockchain. Its cumulative tokenized stock volume recently surpassed $5 billion.
Retail Participation and Selling Pressure
Despite the price gains, technical indicators revealed mixed signals. Retail Futures activity pushed trading frequency into elevated territory, suggesting smaller traders increasingly entered leveraged positions as prices climbed. However, the 90-day Futures Taker CVD maintained taker-sell dominance across derivatives markets, indicating aggressive profit-taking by informed traders.
The MACD indicator remained supportive with a positive histogram reading of 0.0341, but the RSI breached 72.27, signaling overbought conditions.
Technical Outlook and Resistance Levels
RAY slipped below the $1.80 resistance level after failing to sustain the $1.85 swing high, trading at approximately $1.77 at press time. Reclaiming $1.80 is crucial for upside continuation, according to technical analysis.
Liquidation data shows the strongest selling clusters concentrated around $1.64–$1.66. A sustained rejection at $1.80 could push the token toward that lower liquidity zone, though such a correction would not invalidate the broader uptrend while $1.2202 remains protected.
